In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Hundreds of Kansas pharmacies are working to make their message clear: They need pharmacy benefit manager (PBM) reforms.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for cancer, AIDS, multiple sclerosis and other serious maladies far over the ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Mark Cuban's Cost Plus Drug Company has rapidly expanded over the past year. It offers over 6,000 medicines and provides ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.